Lifestyle Interventions for ADHDMay 4th 2022
In this podcast, Psychiatric Times editor-in-chief Dr. John J. Miller interviews Dr. Stephen Faraone, distinguished professor and vice chair of research of psychiatry and behavioral sciences at Upstate Medical University in Syracuse, New York, about the evolving world of nonpharmacologic interventions for ADHD, in particular digital therapeutics.
What Will the Future of Alzheimer Disease Treatment Look Like?July 23rd 2021
Although the new drug aducanumab has grabbed all the headlines, the future of Alzheimer treatment may be just as much about public health campaigns as it is about psychopharmacology. In this episode of Psych Pearls, we find out why.
Teamwork and Trauma: a Conversation With Kasey Grewe, MD, and Niesha Voigt, MDMay 24th 2021
In the early days of the COVID-19 pandemic, physicians were thrust into unfamiliar roles, where they sometimes had to make life and death decisions. Here are a few of their stories.
Dosing Tips for Lithium: How to Improve TolerabilityMay 18th 2021
Although lithium is a first-line treatment that ranks high on the list of patient’s favorites, it has fallen out of general use, particularly in the United States. When lithium works well, its benefits tend to last. It is among the top medications that prevent hospitalization. More in this podcast.
Facing the First Days of the Pandemic: A Conversation With David Chong, MD, and Sara Nash, MDMay 17th 2021
When COVID-19 hit New York City, psychiatrists and other clinicians braved uncertainty and danger. Hear their stories on the PsychPearls podcast.
David Hellerstein, MD: Psychedelic Treatments for Psychiatric DisordersApril 6th 2021
Research on psilocybin, LSD, and other hallucinogens as psychiatric treatments are in their renaissance, transitioning from banned and illegal to potentially useful in changing life for the better in some patients. More in this podcast.